HSBC has launched a pioneering new ethical investment ISA, a child vaccination ISA, which offers the opportunity to make money and at the same time help vaccinate children and save lives in the poorest countries of the world.
The bank is looking to raise at least £50m through its child vaccination ISA, called the Vaccine Investment Plan and Vaccine Investment Isa.
It comes as the Government warns that the economic downturn could push millions of people into extreme poverty and cause the deaths of up to 2.8m children.
The child vaccination ISA works because investors are essentially buying government bonds which help to fund projects operated by the Global Alliance on Vaccines and Immunisation (GAVI), a Geneva-based public-private partnership.
The plan has a five-year-and-one-month life and pays investors 16.2%, together with the original capital on maturity, in June 2014.
The funds raised will be used through the International Finance Facility for Immunisation (IFFIm) and by the Global Alliance for Vaccines and Immunisation (GAVI Alliance), a public-private partnership to support vaccination programmes in 70 of the world's poorest countries.
Find out more about the HSBC vaccination ISA and visit the website here
Printer-friendly version